A murine monoclonal antibody strictly reactive with human peripheral blood monocytes.
We have produced and characterized a novel murine monoclonal antibody (LAM7) of IgG1 isotype which appears specific for peripheral blood monocytes (PBM) on the basis of histochemical and functional studies. By indirect immunofluorescence, including FACS analysis, the antibody reacts with 90 +/- 6% of PBM and with monocytic leukemias, while it is totally unreactive with B and T lymphocytes, platelets, granulocytes, peripheral macrophages, dendritic cells, large granular lymphocytes, and nonmonocytic leukemias. The antigen-presenting capacity of peripheral blood mononuclear cells is abolished by treatment with MoAb LAM7 in an antiglobulin-complement-mediated cytotoxicity test, and restored by addition of purified PBM. The progressive disappearance of the antigen recognized by LAM7 from PBM within approximately 3 days in culture, and its absence from both bone marrow precursors and tissue macrophages, define it as a line-specific and stage-specific differentiation.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology* / Q000502:physiology; D000938:Antigen-Presenting Cells / Q000276:immunology / Q000502:physiology; D001773:Blood Cells / Q000276:immunology*; D001853:Bone Marrow / Q000276:immunology; D001854:Bone Marrow Cells; D002454:Cell Differentiation; D002460:Cell Line; D003165:Complement System Proteins / Q000502:physiology; D000939:Epitopes; D006801:Humans; D007942:Leukemia, Experimental / Q000276:immunology / Q000473:pathology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000276:immunology / Q000473:pathology; D051379:Mice; D009000:Monocytes / Q000276:immunology*; D012513:Sarcoma, Experimental / Q000276:immunology / Q000473:pathology; D013997:Time Factors
D000911:Antibodies, Monoclonal; D000939:Epitopes; D003165:Complement System Proteins